CC
CORZ icon

Cowbird Capital’s Core Scientific CORZ Stock Holding History

Cowbird Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200,000
Closed -$1.86M – 3
2024
Q2 		$1.86M Buy
+200,000
New +$1.02M 2.14% 12

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $47.4M AUM 177.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cowbird Capital's CORZ Position: Q3 2024 in Review

Cowbird Capital sold out of Core Scientific (CORZ) in Q3 2024, closing a stake of 200,000 shares — an estimated $1.86M sold.

Cowbird Capital first reported a position in CORZ in Q2 2024 and held it in 1 quarter. The position peaked at $1.86M in Q2 2024. 249 funds tracked by Wall St. Rank hold CORZ as of Q3 2024.

  • Cowbird Capital reported no remaining Core Scientific position as of Q3 2024 after selling out during the quarter.
  • Cowbird Capital sold 200,000 Core Scientific shares in Q3 2024, an estimated $1.86M.
  • Cowbird Capital first reported a position in Core Scientific in Q2 2024 and held it in 1 quarter.
  • Cowbird Capital's Core Scientific position peaked at $1.86M in Q2 2024.
  • 249 funds tracked by Wall St. Rank held Core Scientific as of Q3 2024.

Based on Cowbird Capital's 13F filing for Q3 2024.